Loading…

VEGF b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

Saved in:
Bibliographic Details
Published in:British journal of cancer 2008-04, Vol.98 (8), p.1366-1379
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6604308